ArticleJournal of chemical information and modeling2026
Persistent Local Laplacian Prediction of Protein-Ligand Binding Affinities.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Accurate prediction of protein-ligand binding affinity remains a central challenge in structure-based drug discovery. The effectiveness of machine learning models critically depends on the quality of molecular representations, for which advanced mathematical frameworks provide powerful tools. In this work, we employ a novel mathematical theory, termed the persistent local Laplacian (PLL), to construct molecular descriptors that capture localized geometric and topological features of biomolecular structures. The PLL framework addresses key limitations of traditional topological data analysis methods, such as persistent homology and the persistent Laplacian, which are often insensitive to local structural variations, while maintaining high computational efficiency. The resulting molecular descriptors are integrated with advanced machine learning algorithms to develop accurate predictive models for protein-ligand binding affinity. The proposed models are systematically evaluated on three well-established benchmark datasets, including PDBbind-v2007, PDBbind-v2013, and PDBbind-v2016, demonstrating consistently strong and competitive predictive performance. Computational results show that the PLL-based models outperform existing approaches, highlighting their potential as a powerful tool for drug discovery, protein engineering, and broader applications in science and engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.